Skip to main content

Table 5 Comparison of liver function indexes before and after DEB-TACE and cTACE

From: Callispheres® drug-eluting beads transarterial chemoembolization might be an efficient and safety down-staging therapy in unresectable liver cancer patients

Liver function indexes

DEB-TACE group (N = 15)

cTACE group (N = 8)

DEB-TACE vs cTACE

Before TACE

After TACE 1 month

Before TACE

After TACE 1 month

p-valuea

p-valueb

ALB (g/L)

42.4 ± 3.75

39.8 ± 4.24

41.9 ± 4.32

38.9 ± 4.15

0.775

0.630

TP (g/L)

70.5± 5.62

67.4 ± 3.69

71.7 ± 4.21

69.4 ± 3.78

0.603

0.233

TBIL (μmol/L)

12.51 ± 6.28

19.67 ± 8.54

14.29 ± 4.36

16.44 ± 3.54

0.484

0.322

TBA (μmol/L)

7.3 ± 3.24

8.1 ± 2.25

8.6 ± 4.63

8.9 ± 3.47

0.439

0.509

ALT (U/L)

41.4 ± 18.21

46.8 ± 15.37

39.14 ± 19.21

40.95 ± 20.88

0.784

0.451

AST (U/L)

43.57 ± 25.33

48.63 ± 16.34

45.27 ± 30.22

46.5 ± 18.25

0.887

0.778

AFP (ng/mL)

1257.4 ± 631.8

268.8 ± 96.5

1182 ± 531.2

421.3 ± 113.2

0.777

0.003*

  1. a, comparison between DEB-TACE and cTACE before TACE by using t-test. b, comparison between DEB-TACE and cTACE at 1 month by using t-test
  2. *p < 0.05